Welcome to our dedicated page for Butterfly Network SEC filings (Ticker: BFLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Butterfly Network, Inc. (NYSE: BFLY) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings give investors and analysts detailed insight into Butterfly’s financial reporting, corporate actions and material events related to its handheld ultrasound devices, Ultrasound-on-Chip™ semiconductor technology and digital health software platforms.
Recent Form 8-K filings for BFLY cover several key topics. Some 8-Ks furnish press releases announcing quarterly financial results and preliminary revenue expectations, along with business updates on AI initiatives, chip development milestones and enterprise software such as Compass™ and Compass AI™. Other 8-Ks describe executive leadership changes, including the appointment of a new Chief Financial Officer and related compensation and severance arrangements for finance executives.
Butterfly’s filings also document material agreements. For example, an 8-K dated November 17, 2025 describes a Co-Development and Licensing Agreement with Midjourney, Inc., under which Butterfly grants an exclusive, non-transferable license within a specified field of use to certain Ultrasound-on-Chip technology, software and backend technology, in exchange for specified fees, milestone payments, revenue sharing and chip-related payments. This type of filing helps readers understand how Butterfly’s semiconductor platform is being licensed to partners.
Another notable 8-K, dated January 13, 2026, reports that the New York Stock Exchange has determined to commence proceedings to delist Butterfly’s public warrants (ticker BFLY WS) and suspend trading in those warrants due to "abnormally low selling price" levels under NYSE rules. The filing states that this action does not affect trading in Butterfly’s Class A common stock, which continues on the NYSE under the symbol BFLY.
On Stock Titan, these SEC documents are supplemented with AI-powered summaries that highlight the main points of each filing, helping readers quickly understand topics such as results of operations, material contracts, leadership changes and listing status. Users can review Forms 8-K for event-driven updates, and refer to annual and quarterly reports (Forms 10-K and 10-Q) for broader financial and operational details as they become available through the SEC’s EDGAR system.
Butterfly Network, Inc. reported that one of its directors bought 185,261 shares of Class A common stock on December 15, 2025 in an open-market purchase. The shares were acquired at a weighted average price of $3.083 per share through The Phanstiel Trust u/a/d 2/5/02, which now holds 185,261 shares indirectly for the reporting person. Separately, the director also holds 365,505 shares of Class A common stock directly.
Butterfly Network Inc. stockholder Dr. Jonathan Rothberg has filed a notice to sell up to 284,986 shares of the company’s common stock through broker Jefferies LLC on the NYSE, with an approximate sale date of 12/16/2025.
The shares to be sold were originally acquired on 08/31/2014 in a private cash purchase from Butterfly Network Inc. The notice states that 226200000 shares of common stock were outstanding.
The document also lists multiple sales by Rothberg over the past three months, including 1110579 shares sold on 11/24/2025 for gross proceeds of 3503032.70 and 769327 shares sold on 12/08/2025 for 2517776.00.
Butterfly Network director and 10% owner Larry Robbins reported buying 21,370 shares of Class A common stock on December 11, 2025 at a weighted average price of $3.0169. The filing notes these were open-market purchases, with individual trade prices ranging from $3.015 to $3.02.
After this transaction, Robbins beneficially owned 14,335,055 shares indirectly through the Glenview Investment Funds and 4,546,687 shares indirectly through Longview Investors LLC or its affiliates, plus 365,505 shares held directly. The direct holdings include 80,434 unvested restricted stock units, each representing one share, which vest in full at Butterfly Network’s 2026 annual stockholders meeting, subject to Robbins’ continued service on the board. Footnotes explain that Glenview and Longview are the record holders, that Robbins may be deemed to share voting and dispositive power, and that he disclaims beneficial ownership beyond any pecuniary interest.
Butterfly Network, Inc. (BFLY) has a notice of proposed sale of common stock by Dr. Jonathan Rothberg. The filing covers 601308 shares of common stock to be sold through Jefferies at 520 Madison Ave, New York, with an aggregate market value of 1902658.00. The table also shows 226200000 shares outstanding and an approximate sale date of 12/15/2025 on the NYSE.
The securities to be sold were acquired on 08/31/2014 in a private purchase from Butterfly Network Inc. for cash. The filing also lists multiple recent sales of Butterfly Network common stock by Dr. Rothberg over the past three months, including 100502 shares on 11/03/2025 for gross proceeds of 309361.24 and 1110579 shares on 11/24/2025 for gross proceeds of 3503032.70, along with additional transactions in November and December 2025.
Butterfly Network, Inc. insider Jonathan M. Rothberg, Ph.D., a director and 10% owner, reported multiple open-market sales of Class A common stock in mid-December 2025 under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025 for estate planning purposes. On December 10, 2025, an affiliated entity, EJR TR, LLC, sold 288,918 Class A shares at a weighted average price of $3.1332 per share. On December 11, 2025, EJR TR, LLC sold 123,354 Class A shares at a weighted average price of $3.0816 per share. On December 12, 2025, EJR TR, LLC sold 82,262 Class A shares and JNR TR, LLC sold 111,031 Class A shares, each at a weighted average price of $3.0804 per share. Following these transactions, Rothberg continues to report indirect holdings in multiple entities and disclaims beneficial ownership beyond his pecuniary interest.
Butterfly Network insider files to sell additional shares under Rule 144. A holder of Butterfly Network common stock plans to sell 193,293 shares through broker Jefferies on or about 12/12/2025, with an aggregate market value of $596,270.00. The notice states that 226,200,000 common shares were outstanding.
The 193,293 shares were originally acquired on 08/31/2014 via a private cash purchase from Butterfly Network Inc. The same seller has already completed multiple open‑market sales of common stock over the prior three months, including 1,110,579 shares on 11/24/2025 for gross proceeds of $3,503,032.70 and 769,327 shares on 12/08/2025 for $2,517,776.00.
Butterfly Network Inc. has a shareholder filing a notice under Rule 144 to sell restricted common stock. The filing covers 123,354 shares of common stock to be sold through Jefferies on the NYSE, with an approximate sale date of December 11, 2025. The issuer reports 226,200,000 common shares outstanding.
The shares to be sold were originally acquired on August 31, 2014 in a private cash purchase from Butterfly Network Inc. Over the past three months, the same seller has reported multiple open-market sales of Butterfly Network common stock, including 1,110,579 shares on November 24, 2025 for gross proceeds of 3,503,032.70 and 769,327 shares on December 8, 2025 for gross proceeds of 2,517,776.00.
Butterfly Network, Inc. insider activity shows a director and 10% owner reporting sales of Class A common stock. On December 8, 2025, entities associated with the reporting person sold 543,601 Class A shares and 225,726 Class A shares at a weighted average price of $3.2727 per share. On December 9, 2025, an associated entity sold an additional 176,070 Class A shares at a weighted average price of $3.1054 per share. The filing states these transactions were made under a Rule 10b5-1 trading plan adopted on March 5, 2025 for estate planning purposes. After these sales, the reporting person continues to hold indirect beneficial ownership in Class A and Class B shares through multiple LLC and trust entities.
Butterfly Network Inc. shareholder Dr. Jonathan Rothberg filed a Form 144 notice to sell up to 288,918 shares of common stock through Jefferies on the NYSE around 12/10/2025. The shares to be sold have an indicated aggregate market value of $905,237.00, compared with 226,200,000 shares of common stock outstanding.
These shares were originally acquired on 08/31/2014 via a private purchase from Butterfly Network Inc. for cash. The filing also lists multiple recent sales of the company’s common stock by Dr. Rothberg during the prior three months, including 1,110,579 shares sold on 11/24/2025 for gross proceeds of $3,503,032.70. By signing, the seller represents that he is not aware of undisclosed material adverse information about the company.
Butterfly Network, Inc. (BFLY) reported an equity award to its Executive Vice President and Chief Financial Officer in the form of restricted stock units (RSUs) on December 8, 2025. The officer received 863,247 RSUs, each convertible into one share of Class A common stock, with one-third vesting on December 8, 2026 and the rest vesting annually over the following two years, subject to continued service.
The officer also received 431,623 performance-based RSUs. These vest in three equal tranches if the stock price reaches or exceeds $3.00, $4.50, and $6.00 per share, respectively, for 20 consecutive trading days before December 8, 2030, and if the officer remains in service through each vesting date. The reported acquisition price for the RSUs is $0 as they are part of compensation.